The Patent Finder
TH

Therapeuticsmd, Inc.

First filing 2009
OverviewNotableFeesChangesFamiliesPatent listSources & methods

50 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.

The next term ends in Oct 2032. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2032
Next term end
5
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 25, 2027
  • 1 fee due Mar 3, 2027
    The maintenance fee for Vaginal Inserted Estradiol Pharmaceutical Compositions and Methods (US 10,398,708) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Natural Combination Hormone Replacement Formulations and Therapies (US 11,793,819) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 2 fees due May 10 to 12, 2027 · next May 10
  • 2 fees due Jul 9 to 21, 2027 · next Jul 9
  • 1 fee due Aug 25, 2027
    The maintenance fee for Vaginal Inserted Estradiol Pharmaceutical Compositions and Methods (US 10,568,891) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
  • 1 fee due Sep 22, 2027
    The maintenance fee for Vaginal Inserted Estradiol Pharmaceutical Compositions and Methods (US 9,289,382) comes due Sep 22, 2027. Unpaid by Mar 22, 2028, it lapses early.
  • 1 fee due Oct 5, 2027
    The maintenance fee for Natural Combination Hormone Replacement Formulations and Therapies (US 9,301,920) comes due Oct 5, 2027. Unpaid by Apr 5, 2028, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Progesterone Formulations (US 10,639,375) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 17, 2026

What they patent

The 4 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US D801,518Pharmaceutical Capsule
In force
 · High confidence
In forceHigh confidence
US 8,633,178Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,846,648Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,846,649Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,933,059Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,987,237Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,987,238Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,993,548Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 8,993,549Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
US 9,006,222Natural Combination Hormone Replacement Formulations and Therapies
In force
 · High confidence
In forceHigh confidence
10 of 50 patents shown.
Pro members see all 50.
Pro members: see all 50 patents
Also on record, not counted in the 50: 10 patents ended · 7 applications pending · 35 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited